Thursday, October 30, 2014

Insurer had duty to defend against defamation claims Health plan’s comments about compounded drugs covered under its policy


A liability insurer had a duty to defend a health plan against a defamation suit brought by compounding pharmacies in connection with statements the plan made when it decided to stop covering “compounded medications,” a Superior Court judge has found. The defendant insurer maintained that the plaintiff health plan’s decision to stop covering compounded drugs breached ...


    Read more: http://masslawyersweekly.com/2014/10/30/insurer-had-duty-to-defend-against-defamation-claims/#ixzz3Hecpteeg

    Alliance of Independent Pharmacists of Texas Reports on Current Contributors to the RX Pac: How many of these are compounding pharmacists?

    Current Contributors Include:

    Chris Alvarado, Oakdell Pharmacy
    Steve Balas, Eagle Lake Drugstore
    Nario Cantu, Cantu's Pharmacy
    John Jeff Carson, Sr., Oakdell Pharmacy
    John Jeff Carson, Jr., Oakdell Pharmacy
    Royce G. "R.G."Cook Jr., Kerrville Drug Company
    Dee Ann Downing, Med Shop Total Care Pharmacy
    Pat & Jan Downing, Med Shop Total Care Pharmacy
    John Dyer, MD Pharmacy
    Robert Floyd, Hance Scarborough
    Benjamin Fry, Frys Prescription Pharmacy
    Maureen Gallagher, Gallagher's Pharmacy
    Harmison, Harmison Pharmacies
    Chuck Hopson
    Ed Horton, Tanglewood Pharmacy
    Gil & Audrey Johnson
    Travis Leeah, Unique Pharmaceuticals
    Georgia Leech, Community Care Pharmacy
    Bruce McAnally, Bonham Family Drug
    Ann & Joey Maxwell, Maxwell Pharmacy
    Artie Mitchell, Medicine Shoppe
    William "Bill" Noble, Noble Strategic
    Larry Oliver, Sonterra RX
    Mark Peippo, Family Pharmacy of Pottsboro
    David Spence, Medicine Shoppe
    William "Bill" Swail, People's Pharmacy
    Anjanette Wyatt, Clinical Care Pharmacy
    Wilson Taylor, Dyer Drug Store
    Jenny Yoakum, Med Shop Total Care Pharmacy

    quoted from here

    Pending Vendor Drug Program (VDP) Reimbursement Changes - Texas Pharmacy Association

    Pending Vendor Drug Program (VDP) Reimbursement Changes - Texas Pharmacy Association

    Over 1.5 Million kids admit using anabolic steroids: Taylor Hooton Foundation

    Taylor Hooton Foundation website post stories relating to steroids

    Here is an example of the stories it features: 
    An 18-year-old man from Australind has pleaded guilty to 14 charges of drug possession after Bunbury police made a major seizure of steroids last month. more

    the website is found at http://taylorhooton.org/tag/anabolic-steroids/

    Question of the Day October 30, 2014 While high-quality testing is important in horse racing, isn't there another aspect that is just if not more important? Isn't it essential to have investigators and people involved with expert knowledge of the questions to ask, what drugs are illegal and legal, and methods used to avoid detection during testing?


    High-quality drug testing helps protect the integrity of California horse racing :: UC Davis News & Information

    High-quality drug testing helps protect the integrity of California horse racing :: UC Davis News & Information

    Horse trainer found guilty of fraud in doping case:Derek Riesberry is the first person in Canada to go before the criminal courts for horse doping.

    http://blogs.windsorstar.com/news/horse-trainer-found-guilty-of-fraud-in-doping-case

    Pharmacy's Legal Challenge Reaches the Texas Supreme ...

    1. Pharmacy's Legal Challenge Reaches the Texas Supreme ...

      www.texaspharmacy.org/.../-Pharmacys-Legal-Challenge-Reaches-the-Te...
      20 hours ago - As you may recall, earlier this year, the Texas Pharmacy Association filed a "friend of ... a physician's order for a compounded medication intended for office use.

    One execution in Texas, another stayed in Missouri - World ...

    1. One execution in Texas, another stayed in Missouri - World ...  

      www.wsws.org/en/articles/2014/.../exec-o30.ht...
      World Socialist Web Site
      6 hours ago - Prison officials reportedly carried out his lethal injection usingcompounded ... use of a made-to-order execution drug produced by an unidentifiedcompounding  ...

    Needle-Free Drug Delivery Devices Market (Jet Injectors, Inhalers, Transdermal Patch and Novel Needle Technology) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    LONDONOct. 29, 2014 /PRNewswire/ -- Needle-free drug delivery devices are novel techniques to introduce drugs into patient's body without invading the skin with a conventional needle. This technology provides effective drug delivery for wide range of drugs; it is bioequivalent to syringe and needle and results in less pain. This report studies the current scenario as well as the future market potential for needle-free drug delivery devices globally. The needle-free drug delivery devices market has been segmented in two major segments, on the basis of technology and applications. Needle-free drug delivery devices market by technology is sub segmented as jet injectors and competing needle-free technologies. Further, competing needle-free technologies are divided into novel needle technology, inhaler technology and transdermal patch delivery. Needle-free drug delivery device market by applications is further segmented as, vaccine delivery (developing immune response), pain management, insulin delivery for diabetes, pediatric injections and other classes. The market for these devices has been extensively analyzed on the basis of factors such as patient compliance and acceptability, increased utility of needle-free devices in various kinds of diseases, opportunities for development of home-care and self medication devices and others. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The needle-free drug delivery devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.
    continue here